BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21207670)

  • 21. Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells.
    Boronkai A; Brubel R; Racz B; Tamas A; Kiss P; Horvath G; Lubics A; Szigeti A; Bellyei S; Toth G; Lakatos A; Reglodi D
    Ann N Y Acad Sci; 2009 Apr; 1163():353-7. PubMed ID: 19456358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
    Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
    J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.
    Vaudry D; Pamantung TF; Basille M; Rousselle C; Fournier A; Vaudry H; Beauvillain JC; Gonzalez BJ
    Eur J Neurosci; 2002 May; 15(9):1451-60. PubMed ID: 12028355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.
    Kasica N; Podlasz P; Sundvik M; Tamas A; Reglodi D; Kaleczyc J
    Neurotox Res; 2016 Nov; 30(4):633-647. PubMed ID: 27557978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pituitary adenylate cyclase activating polypeptide ameliorates the damage and inhibits the increase of intracellular calcium concentration in cultured hippocampal neurons induced by glutamate].
    Dong Y; Tang TS; Lu CL; He C; Dong JB; Huang XY; Sun FZ; Bao X
    Sheng Li Xue Bao; 2000 Oct; 52(5):402-6. PubMed ID: 11941395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis.
    Rácz B; Gasz B; Gallyas F; Kiss P; Tamás A; Szántó Z; Lubics A; Lengvári I; Tóth G; Hegyi O; Roth E; Reglodi D
    Regul Pept; 2008 Jan; 145(1-3):105-15. PubMed ID: 17981349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate.
    Mansouri S; Ortsäter H; Pintor Gallego O; Darsalia V; Sjöholm A; Patrone C
    J Neurosci Res; 2012 Apr; 90(4):759-68. PubMed ID: 22183970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.
    Mijiddorj T; Kanasaki H; Purwana IN; Oride A; Miyazaki K
    Mol Cell Endocrinol; 2011 Jun; 339(1-2):172-9. PubMed ID: 21539889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
    Cavallaro S; D'Agata V; Guardabasso V; Travali S; Stivala F; Canonico PL
    Mol Pharmacol; 1995 Jul; 48(1):56-62. PubMed ID: 7623775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C; Park-Sarge OK
    Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell.
    Yang TT; Tsao CW; Li JS; Wu HT; Hsu CT; Cheng JT
    Neurosci Lett; 2007 Oct; 426(1):45-8. PubMed ID: 17884294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression.
    Onoue S; Hanato J; Yamada S
    FEBS J; 2008 Nov; 275(22):5542-51. PubMed ID: 18959742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway.
    Choi H; Park HH; Koh SH; Choi NY; Yu HJ; Park J; Lee YJ; Lee KY
    Neurotoxicology; 2012 Jan; 33(1):85-90. PubMed ID: 22186599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.